Amaç: Ailesel Akdeniz ateşi (AAA) tanılı hastaların atak ve atak dışı dönemlerindeki nötrofillenfosit oranı (NLO) ve ortalama trombosit hacmi (OTH) değerlerinin tespit edilmesi ve bu değerlerin akut faz belirteçleri ve MEFV gen mutasyonları ile olan ilişkisinin araştırılmasıdır. Gereç ve Yöntemler: Çalışmaya 97 AAA tanılı hasta ve 60 sağlıklı kontrol olgusu dahil edildi. Demografik özellikler ve laboratuvar verileri retrospektif olarak kaydedildi. Bulgular: NLO değeri atak dönemindeki AAA hastalarında ataksız dönem hasta ve kontrol gruplarına göre anlamlı bir şekilde daha yüksek saptanmıştır (sırasıyla 4,67±3,66 vs 1,83±0,64, 4,67±3,66 vs 2,03±0,66). OTH düzeyleri atak döneminde ataksız döneme göre anlamlı olarak daha düşük saptanırken, atak dönemi ile kontrol grubu arasında bir fark tespit edilmedi (sırasıyla 8,53±1,12 vs 8,89±1,28, 8,53±1,12 vs 8,74±0,89). Atak döneminde NLO ile C-reaktif protein (CRP) arasında anlamlı bir korelasyon bulundu. Ataksız dönemdeki NLO değeri, M694V homozigot mutasyonu taşıyan olgularda taşımayanlara göre anlamlı olarak daha yüksek tespit edildi (2,16±0,79 vs 1,76±0,57). Sonuç: AAA tanılı hastaların atak dönemlerinde NLO düzeylerindeki yükselme ve OTH değerlerindeki düşme birer akut faz belirteci olarak kullanılabilir. Ataksız dönemlerdeki NLO düzeylerinde yükselme, özellikle M694V homozigot mutasyonu taşıyan olgularda, bir subklinik inflamasyon belirteci olarak değerlendirilebilir ve amiloidoz gelişimi açısından daha farkında olmamızı sağlar.
Anahtar Kelimeler: Ailesel Akdeniz ateşi; inflamasyon
Objective: To determine the neutrophil-lymphocyte ratio (NLR) and mean platelet volume (MPV) values in the attack and attack-free periods of familial Mediterranean fever (FMF) patients and to investigate their association with acute phase reactants and MEFV gene mutations. Material and Methods: 97 patients with FMF and 60 healthy controls were included in this study. Demographic characteristics and laboratory data were retrospectively recorded. Results: NLR values were significantly higher in the FMF patients at the time of attack than in the attack-free patients and control groups (4.67±3.66 vs 1.83±0.64, 4.67±3.66 vs 2.03±0.66, respectively). MPV levels were significantly lower in the attack period compared with attack-free period and there was no difference between the attack period and the control group (8.53±1.12 vs 8.89±1.28, 8.53±1.12 vs 8.74±0.89, respectively). There was a significant correlation between NLR and C-reactive protein (CRP) during the attack period. The NLR value in the attack-free period was significantly higher in the cases with M694V homozygote mutation than in the cases without this mutation (2.16±0.79 vs 1.76±0.57). Conclusion: Increase in NLR levels and decrease in MPV values can be used as acute phase reactants in the attack periods of patients with FMF. Elevation of NLR levels in attack-free period can be considered as a subclinical inflammatory marker especially in cases with M694V homozygous mutation and allows us to be more alert to the development of amyloidosis.
Keywords: Familial Mediterranean fever; inflammation
- Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017;36(8):1707-13. [Crossref] [PubMed]
- Sönmez HE, Batu ED, Özen S. Familial Mediterranean fever: current perspectives. J Inflamm Res. 2016;9:13-20. [Crossref] [PubMed] [PMC]
- Padeh S, Berkun Y. Familial Mediterranean fever. Curr Opin Rheumatol. 2016;28(5):523-9. [Crossref] [PubMed]
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-54. [Crossref] [PubMed]
- Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther. 2016;14(5):573-7. [Crossref] [PubMed]
- Choi DH, Kang SH, Song H. Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease. Korean J Intern Med. 2016;31(6):1009-17. [Crossref] [PubMed] [PMC]
- Schmoeller D, Picarelli MM, Paz Munhoz T, Poli de Figueiredo CE, Staub HL. Mean platelet volume and immature platelet fraction in autoimmune disorders. Front Med (Lausanne). 2017;4:146. [Crossref] [PubMed] [PMC]
- Ahsen A, Ulu MS, Yuksel S, Demir K, Uysal M, Erdogan M, et al. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation. 2013;36(6):1357-62. [Crossref] [PubMed]
- Kelesoglu FM, Aygun E, Okumus NK, Ersoy A, Karapınar E, Saglam N, et al. Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study. Clin Rheumatol. 2016;35(11):2757-63. [Crossref] [PubMed]
- Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40(10):1879-85. [Crossref] [PubMed]
- Uslu AU, Deveci K, Korkmaz S, Aydin B, Senel S, Sancakdar E, et al. Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever? Biomed Res Int. 2013;2013:185317. [Crossref] [PubMed] [PMC]
- Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5-14.
- Basaran O, Uncu N, Celikel BA, Aydın F, Cakar N. Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients. J Res Med Sci. 2017;15;22:35. [Crossref] [PubMed] [PMC]
- Celikbilek M, Dogan S, Akyol L, Borekci E, Zararsiz G, Kozan M, et al. Neutrophil-lymphocyte ratio in patients with familial Mediterranean fever. J Clin Lab Anal. 2015;29(1): 80-3. [Crossref] [PubMed]
- Mercan R, Bitik B, Tufan A, Bozbulut UB, Atas N, Ozturk MA, et al. The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal. 2016;30(5):597601. [Crossref] [PubMed]
- Sahin S, Senel S, Ataseven H, Yalcin I. Does mean platelet volume influence the attack or attack-free period in the patients with Familial Mediterranean fever? Platelets. 2013;24(4): 320-3. [Crossref] [PubMed]
- Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002;117(2):399-404. [Crossref] [PubMed]
- Bath P, Algert C, Chapman N, Neal B; PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004;35(3):622-6. [Crossref] [PubMed]
- Yüksel O, Helvaci K, Başar O, Köklü S, Caner S, Helvaci N, et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets. 2009;20(4):277-81.[Crossref] [PubMed]
- Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008;75(3):291-4. [Crossref] [PubMed]
- Gasparyan AY, Sandoo A, StavropoulosKalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNFα therapy. Rheumatol Int. 2010;30(8):1125-9. [Crossref] [PubMed]
- Makay B, Türkyilmaz Z, Unsal E. Mean platelet volume in children with familial Mediterranean fever. Clin Rheumatol. 2009;28(8):975-8. [Crossref] [PubMed]
- Coban E, Adanir H. Platelet activation in patients with familial Mediterranean fever. Platelets. 2008;19(6):405-8. [Crossref] [PubMed]
- Abanonu GB, Daskin A, Akdogan MF, Uyar S, Demirtunc R. Mean platelet volume and βthromboglobulin levels in familial Mediterranean fever: effect of colchicine use? Eur J Intern Med. 2012;23(7):661-4. [Crossref] [PubMed]
- Ozkayar N, Piskinpasa S, Akyel F, Dede F, Yildirim T, Turgut D, et al. Evaluation of the mean platelet volume in secondary amyloidosis due to familial Mediterranean fever. Rheumatol Int. 2013;33(10):2555-9. [Crossref] [PubMed]
- Uluca Ü, Ece A, Şen V, Karabel D, Yel S, Güneş A, et al. Usefulness of mean platelet volume and neutrophil-to-lymphocyte ratio for evaluation of children with familial Mediterranean fever. Med Sci Monit. 2014;20:1578-82. [Crossref] [PubMed] [PMC]
- Özer S, Yılmaz R, Sönmezgöz E, Karaaslan E, Taşkın S, Bütün İ, et al. Simple markers for subclinical inflammation in patients with familial Mediterranean fever. Med Sci Monit. 2015;21:298-303. [Crossref] [PubMed] [PMC]
- Lachmann HJ, Sengül B, Yavuzşen TU, Booth DR, Booth SE, Bybee A, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45(6):746-50. [Crossref] [PubMed]
- Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F, et al. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol. 2003;21(4):509-14.
.: Process List